Cargando…

The prognostic factors and multiple biomarkers in young patients with colorectal cancer

The incidence of colorectal cancer (CRC) in young patients (≤50 years of age) appears to be increasing. However, their clinicopathological characteristics and survival are controversial. Likewise, the biomarkers are unclear. We used the West China (2008-2013, China), Surveillance, Epidemiology, and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Mo-Jin, Ping, Jie, Li, Yuan, Adell, Gunnar, Arbman, Gunnar, Nodin, Bjorn, Meng, Wen-Jian, Zhang, Hong, Yu, Yong-Yang, Wang, Cun, Yang, Lie, Zhou, Zong-Guang, Sun, Xiao-Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4445043/ https://www.ncbi.nlm.nih.gov/pubmed/26013439 http://dx.doi.org/10.1038/srep10645

Ejemplares similares

Prognostic Significance and Molecular Features of Colorectal Mucinous Adenocarcinomas: A Strobe-Compliant Study
por: Wang, Mo-Jin, et al.
Publicado: (2015)

Efficacy of Surgery and Adjuvant Therapy in Older Patients With Colorectal Cancer: A STROBE-compliant article
por: Yang, Lie, et al.
Publicado: (2014)

MicroRNA Expression Profile Reveals miR-17-92 and miR-143-145 Cluster in Synchronous Colorectal Cancer
por: Meng, Wen-Jian, et al.
Publicado: (2015)

Can K-ras Gene Mutation Be Utilized as Prognostic Biomarker for Colorectal Cancer Patients Receiving Chemotherapy? A Meta-Analysis and Systematic Review
por: Rui, Yuan-Yi, et al.
Publicado: (2013)

Prognostic Heterogeneity of MRE11 Based on the Location of Primary Colorectal Cancer Is Caused by Activation of Different Immune Signals
por: Fan, Chuan-Wen, et al.
Publicado: (2020)

The Different Roles of hRAD50 in Microsatellite Stable and Unstable Colorectal Cancers
por: Gao, Jingfang, et al.
Publicado: (2008)

Expression of AEG-1 mRNA and protein in colorectal cancer patients and colon cancer cell lines
por: Gnosa, Sebastian, et al.
Publicado: (2012)

WRAP53 is an independent prognostic factor in rectal cancer- a study of Swedish clinical trial of preoperative radiotherapy in rectal cancer patients
por: Zhang, Hong, et al.
Publicado: (2012)

Prognostic value of CD133(+) CD54(+) CD44(+) circulating tumor cells in colorectal cancer with liver metastasis
por: Fang, Chao, et al.
Publicado: (2017)

Interaction of CD200 Overexpression on Tumor Cells with CD200R1 Overexpression on Stromal Cells: An Escape from the Host Immune Response in Rectal Cancer Patients
por: Bisgin, Atil, et al.
Publicado: (2019)

Clinical efficacy of adjuvant chemotherapy in the treatment of pT4 stage II colorectal cancer with defective mismatch repair status: A protocol for systematic review and meta-analysis
por: Huang, Li-Bin, et al.
Publicado: (2020)

CD133(+)CD54(+)CD44(+) circulating tumor cells as a biomarker of treatment selection and liver metastasis in patients with colorectal cancer
por: Fang, Chao, et al.
Publicado: (2016)

Expression of podocalyxin-like protein is an independent prognostic biomarker in resected esophageal and gastric adenocarcinoma
por: Borg, David, et al.
Publicado: (2016)

Expressions of miR-302a, miR-105, and miR-888 Play Critical Roles in Pathogenesis, Radiotherapy, and Prognosis on Rectal Cancer Patients: A Study From Rectal Cancer Patients in a Swedish Rectal Cancer Trial of Preoperative Radiotherapy to Big Database Analyses
por: Meng, Wen-Jian, et al.
Publicado: (2020)

Molecular correlates and prognostic significance of SATB1 expression in colorectal cancer
por: Nodin, Björn, et al.
Publicado: (2012)

FXYD-3 expression in relation to local recurrence of rectal cancer
por: Loftas, Per, et al.
Publicado: (2016)

Expression of IFITM1 as a prognostic biomarker in resected gastric and esophageal adenocarcinoma
por: Borg, David, et al.
Publicado: (2016)

Discovery of KIRREL as a biomarker for prognostic stratification of patients with thin melanoma
por: Lundgren, Sebastian, et al.
Publicado: (2019)

Incident urothelial cancer in the Malmö Diet and Cancer Study: cohort characteristics and further validation of ezrin as a prognostic biomarker
por: Wennersten, Christoffer, et al.
Publicado: (2014)

Podocalyxin-like and RNA-binding motif protein 3 are prognostic biomarkers in urothelial bladder cancer: a validatory study
por: Boman, Karolina, et al.
Publicado: (2017)

Validation of podocalyxin-like protein as a biomarker of poor prognosis in colorectal cancer
por: Larsson, Anna, et al.
Publicado: (2012)

Cyclin D1 expression in colorectal cancer is a favorable prognostic factor in men but not in women in a prospective, population-based cohort study
por: Wangefjord, Sakarias, et al.
Publicado: (2011)

Nuclear expression of lysyl oxidase enzyme is an independent prognostic factor in rectal cancer patients
por: Liu, Na, et al.
Publicado: (2016)

Prognostic role of the lymph node ratio in node positive colorectal cancer: a meta-analysis
por: Zhang, Ming-Ran, et al.
Publicado: (2016)

Sex differences in the prognostic significance of KRAS codons 12 and 13, and BRAF mutations in colorectal cancer: a cohort study
por: Wangefjord, Sakarias, et al.
Publicado: (2013)

Severe Hypoglycemia Caused by Recurrent Sarcomatoid Carcinoma in the Pelvic Cavity: A Case Report
por: Fang, Chao, et al.
Publicado: (2015)

Rare case of drain-site hernia after laparoscopic surgery and a novel strategy of prevention: A case report
por: Gao, Xiang, et al.
Publicado: (2020)

Tumor-Associated CD68(+), CD163(+), and MARCO(+) Macrophages as Prognostic Biomarkers in Patients With Treatment-Naïve Gastroesophageal Adenocarcinoma
por: Jeremiasen, Martin, et al.
Publicado: (2020)

Prognostic value of nuclear FBI-1 in patients with rectal cancer with or without preoperative radiotherapy
por: Wang, Chao-Jie, et al.
Publicado: (2019)

PINCH is an independent prognostic factor in rectal cancer patients without preoperative radiotherapy - a study in a Swedish rectal cancer trial of preoperative radiotherapy
por: Holmqvist, Annica, et al.
Publicado: (2012)

GLUT-1 overexpression as an unfavorable prognostic biomarker in patients with colorectal cancer
por: Yang, Jing, et al.
Publicado: (2016)

Expression of Aldehyde Dehydrogenase 1A1 (ALDH1A1) as a Prognostic Biomarker in Colorectal Cancer Using Immunohistochemistry
por: Yang, Wangshuo, et al.
Publicado: (2018)

Predictive Role of Biopsy Based Biomarkers for Radiotherapy Treatment in Rectal Cancer
por: Wen, Yugang, et al.
Publicado: (2020)

Discovery of dachshund 2 protein as a novel biomarker of poor prognosis in epithelial ovarian cancer
por: Nodin, Björn, et al.
Publicado: (2012)

Clinicopathological correlates and prognostic significance of KRAS mutation status in a pooled prospective cohort of epithelial ovarian cancer
por: Nodin, Björn, et al.
Publicado: (2013)

Prognostic and predictive significance of podocalyxin-like protein expression in pancreatic and periampullary adenocarcinoma
por: Heby, Margareta, et al.
Publicado: (2015)

Elevated kinesin family member 26B is a prognostic biomarker and a potential therapeutic target for colorectal cancer
por: Wang, Jingtao, et al.
Publicado: (2015)

A cohort study of the prognostic and treatment predictive value of SATB2 expression in colorectal cancer
por: Eberhard, J, et al.
Publicado: (2012)

Prognostic impact of tumour-associated B cells and plasma cells in epithelial ovarian cancer
por: Lundgren, Sebastian, et al.
Publicado: (2016)

Is Ep-CAM Expression a Diagnostic and Prognostic Biomarker for Colorectal Cancer? A Systematic Meta-Analysis
por: Han, Susu, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_if4dqj8nkn40cj0kq48sohu0j0